Antibiotics--exam 1 Flashcards
Penicillin (prototype)
- β lactam ring forms irreversible covalent acyl-bond w/ transpeptidase enzyme (PBP)
- Prevent x-linking (transpeptidation)
- -cell continues to degrade wall (remodel)→ osmotic lysis
- time dependent killing
- most rapidly excreted drug by normal kidney
- -can be partially blocked → probenecid
- -can exacerbate gout
- one of the most NON-TOXIC and SAFEST drugs
- can produce all 4 types of hypersensitivities
- -**most allergenic of Abx, then Sulfa then cephalosporins
- -all are cross-allergic & sensitizing
- -procaine-penicillin combo is worst
Toxicities (mostly dose dependent)
1) tissue irritation
2) excess Na, K+ from large doses → cardiac & renal toxicity
3) Soft frothy stools & diarrhea → broader spectrum is worse
- overgrowth of staph, pseudomonas, proteus or yeast
4) Superinfection
5) Jarisch-Herxheimer Rxn → severe febrile reaction
- -occurs in syphilis or leptospirosis due to massive killing
Penicillin G potassium (IV, IM)
Penicillin G benzathine (IM depot)
Penicillin G procaine (IM)
Penicillin V (acid resistant → oral)
Natural penicillin
- Penicillin G benzathine → longest acting preparation
- -Treat → Syphilis (DOC) & Rheumatic fever
- -mild/mod infections
- -prophylaxis
- activity against gram positives→ **HIGHEST
- spectrum→ some G-
- activity against anaerobes→ some
- activity against pseudomonas aeruginosa→ none
- penicillinase resistance→ readily inactivated
- acid resistance→ only penicillin V
- main route of elimination→ active transport in kidney
- -no metabolism → no drug interactions
- CNS penetration→ poor penetration (↑ w/ inflammation)
Nafcillin (parenteral)
- Oxacillin (oral)
- Dicloxacillin (oral)
- Methicillin
Penicillinase resistant penicillins*
(Anti-staphylococcal penicillins)
- -**DOC for penicillinase producing staph. auerus
- Methicillin was most common cause of interstitial nephritis
- activity against gram positives→ lower against certain
- spectrum→ some
- activity against anaerobes→ some
- activity against pseudomonas aeruginosa→
- penicillinase resistance→ resistant
- acid resistance→ some & **highly protein bound
- -loading dose → 2x usual dose
- main route of elimination→ **hepatic & renal excretion
Amoxicillin
–Ampicillin
Extended spectrum penicillins* (amino penicillins)
- activity against gram positives→ lower
- spectrum→ extended G- (PeSSkEy, H. influ)
- activity against anaerobes→ yes; w/ penicillinase inhibitors
- activity against pseudomonas aeruginosa→ none
- penicillinase resistance→ susceptible
- acid resistance→ resistant
- main route of elimination→ urinary excretion
- Ampicillin rash → not allergic or itchy
- -can occur w/ EBV
Piperacillin
–Ticarcillin
Antipseudomonal Penicillin
- activity against gram positives→ lower
- spectrum→ same as amoxicillin + some G- enteric bacilli
- activity against anaerobes→ yes; w/ penicillinase inhibitors
- activity against pseudomonas aeruginosa→ YES
- penicillinase resistance→ susceptible
- acid resistance→ sensitive
- main route of elimination→ renal excretion
Aztreonam
Monobactam (same mxn as penicillin)
- relatively resistant to β-lactamases
- Targets → Gram negative rods (including Pseudomonas & Serrate)
- NO ACTIVITY → Gram+ or anaerobes
- Safe in pts w/ Penicillin allergy
Imipenem, Cilastatin
- -meropenem
- -ertapenem
- -doripenem
Carbapenems (same mxn as penicillin)
- broad spectrum → anaerobes, G+, G- rods
- -Pseudomonas may develop res. → add amino glycoside
- Imipenem → inactivated by renal dehydropeptivdases
- -must be given w/ Cilastatin
- -can cause seizures
- Meropenem → resistant to dehydropeptidases
- less likely to cause seizures
- Ertapenem → highly stable against β-lactamases
- particularly effective against Enterobacteriaceae
-Doripenem → good activity against pseudomonas
Clavulanic acid
- -sulbactam
- -tazobactam
Beta-lactamase inhibitors
- resemble beta-lactam molecule
- weak antibacterial action
- inhibit many, but not all BETA LACTAMASES
- -most active against → plasmid encoded lactamases
Vancomycin
–teicoplanin
Inhibitor of cell wall synthesis (glycopeptides)
- binds terminal D-alanine D-alanine of nascent PG pentapeptide
- → inhibits transglycosylase → no chain elongation
- -**inhibits transpeptidation (cross linking)
- ONLY effective for Gram+
- staph aureus & epidermidis
- strep & enterococci, corynebacterium & clostridium
- penicillin and methicillin resistant staphylococcal (DOC)
- -patient w/ penicillin allergy
- parenteral
- -sometimes oral → GI infections (pseudomem. colitis)
- poor CNS penetration → don’t use for meningitis
Resistance → D-Ala-D-Ala → D-Ala-D-LACTATE
- excreted unchanged in kidney → marked accumulation
- nephrotoxicity in presence of renal insufficiency
- -uremia after high dose may be FATAL
- ototoxic
- red man syndrome → histamine release
Telavancin
Inhibitor of cell wall synthesis (lipoglycopeptide)
- binds terminal D-alanine D-alanine of nascent PG pentapeptide (no elongation or x-linking like vancomycin)
- ↑ membrane permeability (like daptomycin)
- bactericidal → select Gram+, MRSA
- complicated skin & skin structure infections
- take 1x day
- CI → pregnancy & renal insufficiency
Fosfomycin
Inhibitor of cell wall synthesis
- inhibits one of the key 1st steps of peptidoglycan synthesis
- -irreversibly inactivates enolpyruvyl transferase
- -nucleotide precursors accumulate → death & lysis
- active against Gram+ & Gram-
- -uncomplicated lower UTI in women
-taken orally → excreted by kidney
Bacitracin
Inhibitor of cell wall synthesis
- inhibits activation (dephosporylation) of the lipid carrier
- -no transport of peptidoglycan subunits (water soluble) through cell membrane
- accumulate in cytoplasm→ not added to growing PG chain
-mainly target Gram+
-topical or parenteral
–serious nephrotoxicity w/ PE admin
–most commonly use in combo w/ polymyxin B & Neomycin
topically→ prevent superficial skin and eye infection
Cycloserine
Inhibitor of cell wall synthesis
- analog of D-alanine
- competes w/ D-alanine for 2 enzymes (incorporate alanine)
- -inhibits both enzymes & peptidoglycan synthesis
- → weak cell wall & eventual cell lysis
- 2nd line against active pulmonary & extra-pulm TB
- severe CNS toxicity (anxiety, confusion, memory loss, seizures, etc.)
Cephalosporins
- β lactam ring forms irreversible covalent acyl-bond w/ transpeptidase enzyme (PBP)
- Prevent x-linking (transpeptidation)
- -cell continues to degrade wall (remodel)→ osmotic lysis
- has a 7-methyl group → ↑ resistance to β-lactamase
- resistance mxn → same as w/ penicillin
- most have some plasma protein binding
- penetrate most tissues → not eye & CNS
- most excreted unchanged by kidney
- -Probenecid → ↓ excretion & ↑ 1/2 life
- -adjust dosage w/ renal insufficiency
Adverse
- pseudomembranous colitis → ↑ specturm ↑ chance
- dose dependent renal tubular necrosis
- synergistic nephrotoxicity w/ aminoglycosides (esp in elderly)
Properties of ICWS
- activity against gram positives→
- spectrum→
- activity against anaerobes→
- activity against pseudomonas aeruginosa→
- penicillinase resistance→
- acid resistance→
- main route of elimination→
- CNS penetration→
Mechanisms of Bacterial Resistance
- Inactivation by penicillinase (may be inducible)
- ↓ permeability of outer membrane (only G-) → prevents reaching PBP
- Alteration of PBP (mxn if resistant to Methicillin)
- Autolytic enzymes not activated (Listeria & Staph)
- Lack cell wall (Mycoplasma)
- Non-peptidoglycan cell wall (Chlamydia)
Daptomycin
Inhibitor of cell wall synthesis (lipopeptide)
- binds to bacterial membranes → rapid depolarization
- → inhibits protein, DNA, and RNA synthesis → death
- bactericidal → Gram+
- NO MXN OF RESISTANCE
-IV → excreted unchanged by kidneys
Cefazolin (IV)
- Cefadroxil Monohydrate (oral)
- Cephalexin (oral)
First Gen. Cephalosporin (narrow spectrum)
- good activity → Gram + (EXCEPT enterococci)
- -most G+ cocci except → enterocci, MRSA, MRSEpi
- -NO β-lactam is effective against MRSA
- moderate activity → Gram -
- good activity → E. coli, Klebsiella pneum., Proteus marbles
- -1st & 2nd gen. → DOC for E. coli
Cefazolin → surgical prophylaxis
Cefoxitin (IM, IV)
- Cefaclor (Oral)
- Cefotetan (IM, IV)
- Loracarbef (Oral)
Second Gen. Cephalosporin (intermediate spectrum)
- good activity → Gram +
- increased activity → Gram -
- good activity → E. coli, Klebsiella pneum., Proteus marbles
- -1st & 2nd gen. → DOC for E. coli
Cefaclor → serum sickness like SE
Cefotetan & Loracarbef → disulfiram like effect
–inhibits acetyladehyde deydrogenase
Cefotaxime Sodium
- Ceftizoxime
- Ceftazidime
- Ceftriaxone
- Cefixime
Third Gen. Cephalosporin (broad-spectrum)
→ diff from 1st & 2nd gen
- pretty good G+ and G- coverage
- -↓ G+ cocci but ↑ enterobacteriaceae coverage
- even more resistant to B-lactamase
- some will get into CNS → Cefotaxime & Ceftriaxone
- effective against → Pseudomonas
- first line choice → Salmonella
- mostly/half metabolized → liver
- -if it is lipid soluble wont be excreted in kidney and must be conjugated in liver
Ceftriaxone → ↑ hepatic elimination --DOC gonnorhea --penicillin resistant strep. pneumoniae Cefixime → ORAL Ceftizoxime & Ceftazidime → antipseudomonal
Cefepime
Fourth Gen. Cephalosporin
- good G+ and G- (similar to 3rd gen)
- more resistant to some β-lactamases
- anti-pseudomonal (similar to Ceftazidime)
- better activity → Enterobacter & Citrobacter
- reserved for ICU and severe systemic infections
- ↑ penetrvity → Enterobacter & Citrobacter
- reserved for ICU and severe systemic infections
-penetrates CSF
Ceftarolime fosamil
Unnamed gen. Cephalosporin
effective against MSSA, MRSA, & VRSA
- high affinity to → PBP 2A (responsible for resistance)
- -encded by mega
- no antipseudomonal
Organisms not reliably covered by cephalosporins
- Enterococci → Penicillin
- List. Monocytogenes → Penicillin
- MRSA
- Atypicals → Chlamydia & Mycoplasma
Cephalosporins are 1st choice for infections with:
- Moraxella catarrhalis → 2nd or 3rd gen
- Neisseria gonorrhoeae → ceftriaxone, cefixime (oral)
- E. coli, Klebsiella, Proteus → 1st or 2nd gen.
- Salmonella → 3rd gen
- Penicillin resistant Strep. pneumonia → ceftriaxone
MAY be used:
- Gram + infections in penicillin-sensitve patiens
- mixed infections → cellulitis or skin ulcers in diabetic
- surgical prophylaxis → cefazolin
- UTI → excreted & concentrated in urine
Sulfonamide mechanism & uses
Sulfonamide (bacteriostatic)
-competes w/ PABA at dihydropteroate synthase
→ blocks formation of DHF
–folic acid necessary for Purine & DNA synthesis
–susceptible bacteria can’t multiply, grow, or survive
–mammals do not synthesize folic acid like bacteria
-inhibit both Gram+ and Gram-
RESISTANCE
- -↓ sensitivity of target enzyme
- -↑ formation of PABA
- -use of exogenous folate
USES
- DOC→ UTI infections (1st attack & prophylaxis)
- DOC→ Nocardiosis
- Toxoplasmosis & Trachoma
- Pneumocytstis carinii → children and AIDS patients
Sulfonamide distribution, metabolism/excretion, interactions and Toxicity
- good distribution
- -cross placenta and BBB
- Good degree of plasma protein binding → no neg. effect
- ***urine conc. → 10-20x plasma can be reached for UTI
- -at high concentrations → bactericidal
- Metabolized in liver → acetylated products
- Excreted through kidney
- -insoluble (esp. *acidic urine) → crystalluria & renal dmg
- –drink more water or alkalize urine
TOXICITIES
- every organ systems may be adversely affected
- Kernicterus in nursing infant → displaces bound bilirubin →CI infants <2 months
- Drug sensitivy (allergy 6%, 2nd to penicillin)
- Blod dyscrasia, leukopenia, granulocytopenia,
- -thrombocytopenia, agranulocytosis
- Kidney & Liver damage
- Stevens-Johnson syndrom (dermal toxic lysis → lose epi)
- Microscopic hematuria→ crystals damage
- PHOTOSENSITIVITY
Sulfasalazine
Sulfonamide (bacteriostatic)
- competes w/ PABA→ blocks formation of DHF
- -prodrug cleaved GI bacteria→ sulfapyridine + mesalamine
- -local actions of melamine → effectiveness of sulfasalazine
- used to treat Ulcerative Colitis
- oral
Silver Sulfadiazine
Sulfonamide (bacteriostatic)
- exact mechanism is unknown→ dent inhibit FA synthesis
- -damages cell membrane and cell wall
- Topical → prevent & treat infections → 2nd/3rdº burns
- Activity against → Bacteria AND yeast
- does not inhibit CA (Mafenide does)
- doesn’t stain dressing or tissue
Trimethoprimp
Folate Antagonist
- inhibits DHF reductase → blocs formation of THF
- -THF needed for carbon transfer → NA, protein synthesis
- -therapeutic does → no human enzyme inhibition
- activity against Gram+ and Gram-
- commonly used systemically for treatment & prophylaxis:
- -uncomplicated UTI
- –alone may be as effective → recurrent UTI
- -traveler’s diarrhea
- SMX or dapsone → pneumocystis carinii
- can be used w/ impaired renal function or if sulfa drugs can’t be tolerated
- may be TERATOGENIC → don’t take during pregnancy
Co-trimoxazole (Bactrim)
Sulfamethoxazole + Trimethoprim (TMP-SMX)
Sulfonamide Combo
- Sulfamethxazole blocks PABA incorporation to DHF
- Trimethoprim prevents reduction of DHF to THF
- -selective for DHF reductase of lower organisms
- fixed 1:5 ratio (TMP-SMX) → 1:20 serum concentrations
- DOC for uncomplicated UTI (except for enterococci)
- -Prostatitis (along w/ doxycycline & fluoroquinolones)
- DOC for Moraxella catarrhalis
- P. jiroveci pneumonia (also TMP + dapsone)
- -respiratory tract pathogens → pneumococcus
- –Haemophilus, Moraxella catarrhalis, Klebsiella pneumonia
- Shigellosis & systemic salmonella infections
- some non TB myco infections
- MSSA & MRSA
- otitis media
- 2nd line for Listeria
Sulfadoxine + Pyrimethamine
Sulfonamide Combo
pyrimethamine → inhibits parasitic DHF reductase
sulfadoxine → antagonizes PABA
–synergistic activity on FA production
- used in combo → malaria treatment
- -not prophylaxis → fatal toxic epidermal necrolysis